| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 26S proteasome non-ATPase regulatory subunit 14 |
|---|
| Ligand | BDBM83086 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay |
|---|
| IC50 | 7120±405 nM |
|---|
| Citation |  PubChem, PC Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay PubChem Bioassay(2012)[AID] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 26S proteasome non-ATPase regulatory subunit 14 |
|---|
| Name: | 26S proteasome non-ATPase regulatory subunit 14 |
|---|
| Synonyms: | 26S Proteasome regulatory subunit Rpn11 (Rpn11) | POH1 | PSDE_HUMAN | PSMD14 | PSMD14 protein |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 34576.68 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O00487 |
|---|
| Residue: | 310 |
|---|
| Sequence: | MDRLLRLGGGMPGLGQGPPTDAPAVDTAEQVYISSLALLKMLKHGRAGVPMEVMGLMLGE
FVDDYTVRVIDVFAMPQSGTGVSVEAVDPVFQAKMLDMLKQTGRPEMVVGWYHSHPGFGC
WLSGVDINTQQSFEALSERAVAVVVDPIQSVKGKVVIDAFRLINANMMVLGHEPRQTTSN
LGHLNKPSIQALIHGLNRHYYSITINYRKNELEQKMLLNLHKKSWMEGLTLQDYSEHCKH
NESVVKEMLELAKNYNKAVEEEDKMTPEQLAIKNVGKQDPKRHLEEHVDVLMTSNIVQCL
AAMLDTVVFK
|
|
|
|---|
| BDBM83086 |
|---|
| n/a |
|---|
| Name | BDBM83086 |
|---|
| Synonyms: | MLS001156641 | N-[2-(2,3-dimethylanilino)-2-keto-ethyl]-3-(4-keto-5,6,7,8-tetrahydro-3H-benzothiopheno[2,3-d]pyrimidin-2-yl)propionamide | N-[2-(2,3-dimethylanilino)-2-oxoethyl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide | N-[2-[(2,3-dimethylphenyl)amino]-2-oxidanylidene-ethyl]-3-(4-oxidanylidene-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide | SMR000715822 | cid_24980803 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C23H26N4O3S |
|---|
| Mol. Mass. | 438.543 |
|---|
| SMILES | Cc1cccc(NC(=O)CNC(=O)CCc2nc3sc4CCCCc4c3c(=O)[nH]2)c1C |
|---|
| Structure | 
|
|---|
Search and Browse
